EpiPen is an epinephrine injector produced by Mylan, a global specialty pharmaceutical company now part of Viatris after a series of mergers and divestitures. The device is designed for rapid intramuscular epinephrine delivery during anaphylaxis and is regulated as a prescription drug whose formulation, labeling, and recalls are overseen by the FDA. Ownership and operational control have shifted over time, influencing pricing, product availability, and patient access. The following sections clarify the manufacturer, supply chain, and key milestones that define the EpiPen ecosystem.
EpiPen Manufacturer and Corporate Lineage
EpiPen is marketed by Mylan, which was an independent global pharmaceutical company specializing in generic and specialty medicines. In 2020, Mylan combined with Upjohn (a Pfizer division) and Theramex to form Viatris, making Viatris the current parent company of the Mylan brand and EpiPen. Although Viatris holds rights to the legacy Mylan portfolio, specific consumer health and device functions may also involve partnerships with contract manufacturers and specialized suppliers. Key corporate milestones include
| Date or Period | Event | Why It Matters |
|---|---|---|
| 2007 | Mylan acquires Meda Pharmaceutical’s anaphylaxis business | Expands Mylan’s epinephrine portfolio and lays groundwork for EpiPen dominance |
| 2016–2017 | EpiPen pricing and public scrutiny | Brings attention to specialty drug pricing and access issues |
| 2018 | Mylan and Pfizer consumer health joint venture discussions | Signals strategic shifts that precede later consolidation |
| 2020 | Mylan + Upjohn + Theramex = Viatris | Creates Viatris, the current steward of the Mylan brand and EpiPen |
| 2023–2024 | Ongoing product recalls and reformulations | Highlights ongoing quality, safety, and supply chain adjustments |
How EpiPen Is Made and Quality Controls
EpiPen devices are engineered to deliver a precise epinephrine dose reliably in emergency situations. Manufacturing involves sterile assembly of the cartridge, spring-mechanism, and safety features, followed by rigorous release testing. Mylan’s facilities operate under strict current Good Manufacturing Practice (cGMP) standards, and the FDA reviews and audits these sites to ensure compliance. Quality control measures cover
- Dose accuracy and uniformity across batches
- Sterility assurance and particulate monitoring
- Mechanical function of the auto-injector trigger
- Labeling, stability, and shelf-life verification
- Adverse event tracking and corrective actions
These controls are documented in regulatory filings and subject to inspection, providing traceability from raw materials to patient use.
EpiPen vs Adrenaclick: Comparable Devices
While EpiPen is the most recognized brand, other epinephrine auto-injectors exist and may be substituted depending on formulary and provider preference.
| Product | Manufacturer | Notable Features |
|---|---|---|
| EpiPen | Mylan (Viatris) | Well-known brand, widely covered; fixed doses; established training programs |
| Adrenaclick | Kaleo | Distinct ergonomic design; fixed and adjustable dosing options |
| Auvi-Q | Sanofi (with potential contract production) | Voice-guided instructions; dose selection; compact form |
| Epinephrine vial/syringe | Various generic manufacturers | Requires mixing and drawing; not a pre-filled auto-injector |
All authorized epinephrine products must meet FDA standards for safety, efficacy, and usability, though differences in training aids, size, and needle visibility can affect user confidence.
Supply Chain, Recalls, and Availability Factors
The EpiPen supply chain spans active pharmaceutical ingredient (API) sourcing, formulation, device assembly, labeling, and distribution to pharmacies and providers. Disruptions can arise from API shortages, manufacturing deviations, or post-market quality findings. When issues occur, Mylan and Viatris may initiate recalls and issue patient notifications. Key points include
- Recalls are classified by urgency and impact, with Class I indicating serious health risks
- Patients are advised not to delay replacement if their device is recalled
- Healthcare providers and pharmacies often maintain alternative stock, such as Adrenaclick or Auvi-Q
- Prescription benefit managers and plans may influence which product a patient receives
Staying informed through the FDA recall database, the Mylan/Viatris website, and a pharmacist’s guidance helps ensure access to a functioning epinephrine injector when needed.
Key Facts at a Glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Current manufacturer/brand owner | Mylan, now part of Viatris | Corporate filings and FDA records |
| Device type | Epinephrine auto-injector (fixed-dose) | Product labeling and FDA classification |
| Regulatory oversight | FDA approval and cGMP compliance | FDA Drug Approval Packages and inspection reports |
| Notable recalls | Various lot-level recalls for particulate matter and advisory notices | FDA Enforcement Report and company press releases |
| Major competing products | Adrenaclick (Kaleo), Auvi-Q (Sanofi) | FDA approvals and market listings |
FAQ
Reader questions
Is EpiPen still made by Mylan?
Yes, EpiPen is currently marketed by Mylan, which is now under the Viatris umbrella following the 2020 consolidation. The Mylan brand and product portfolio, including EpiPen, are maintained by Viatris.
Where are EpiPen devices assembled?
EpiPen devices are assembled in facilities that follow cGMP standards, typically located in regions where Mylan and Viatris operate manufacturing and quality operations. Specific site details are found in regulatory submissions and FDA establishment registrations.
What should I do if my EpiPen is recalled?
Review the recall notice for specific instructions, which usually advise stopping use immediately and contacting Mylan/Viatris or a pharmacist for a replacement. Do not delay obtaining a replacement epinephrine injector.
Are generic epinephrine auto-injectors available?
Yes, authorized generics and alternative devices such as Adrenaclick and Auvi-Q are available. Some plans may offer these as preferred options, and they are required to meet the same safety and performance standards as the brand product.
How can I verify the manufacturer and check for recalls?
Check the FDA’s recall and enforcement reports, review information on the Mylan/Viatris official site, and consult your pharmacist. The FDA database includes lot numbers, recall classifications, and recommended actions. Understanding who makes EpiPen and how the product is governed helps patients and caregivers make informed decisions about acquisition, use, and response during an emergency.